Opioid Tolerance Treatment Market Size, Share, And Growth Report 2032

Opioid Tolerance Treatment Market: Size

The global Opioid Tolerance Treatment Market size was worth around USD 1923.17 million in 2023 and is predicted to grow to around USD 2643.96 million by 2032 with a compound annual growth rate (CAGR) of roughly 3.6% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Opioid Tolerance Treatment Market on a global and regional level.

Request Free Sample

Opioid Tolerance Treatment Market: Overview

Opioids are pain-relieving drugs that work with opioid receptors present in the human brain cell. The cell sends signals that change the perception of pain and uplifts the sense of pleasure in the body. Opioids are psychotropic substance derived from the opium poppy or developed in laboratories, such as heroin and morphine. Regular use or high dosage can create respiratory depression. The increasing number of chronic diseases, such as cancer, is one of the primary reasons for opioids overdose. According to the World Health Organization, in 2016, 65,632 people died due to overdose opioids, i.e., 21% more than the previous years. Every year, 0.65% of opioid-dependent individuals die due to opioid overdose, as per the W.H.O’s.

The increasing number of orthopedic surgeries is one of the main growth drivers of the global opioid tolerance treatment market. The growing occurrences of disease related to chronic pain, such as arthritis, cancer, and back pain is also propelling the opioids tolerance treatment market globally. Additionally, the escalating rise in the number of road accidents and trauma cases along with continuously growing cases of medical procedures is also boosting the demand for opioid-based pain management treatments, which, in turn, is fuelling the global opioid tolerance treatment market growth.

Request Free Sample

Opioid Tolerance Treatment Market: Segmentation

The study provides a decisive view of the global opioid tolerance treatment market is divided based on drug, administration route, opioid tolerance type, end-user, and region.

Based on drug type, the market includes Alpha2-adrenoceptor agonists, NMDA antagonists, and others. The Alpha2-adrenoceptor agonists are further segmented into Clonidine, Tizanidine, and others. The NMDA antagonists segment is further divided into Dextromethorphan, Ketamine, and others.

On the basis of opioid tolerance type, the global opioid tolerance treatment market is categorized into acquired tolerance and innate tolerance.

By administration route, the market includes enteral and parenteral.

By end-user, the global market comprises hospitals and ASCs, rehabilitation centers, and others.

Opioid Tolerance Treatment Market: Report Scope

Opioid Tolerance Treatment Market: Regional Analysis

The regional segment includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.

The Asia Pacific region is expected to register a high growth rate in the global opioid tolerance treatment market, in terms of market share, over the estimated timeframe. North America accounted for the largest share of the global opioid tolerance treatment market in 2023, owing to the high prevalence of chronic diseases and pain associated with such diseases along with the increasing aging regional population, as geriatric people are more susceptible to pain and requires a high dose of opioids for pain relief.

Opioid Tolerance Treatment Market: Competitive Players

Some major players operating in the global opioid tolerance treatment market are:

• Pfizer
• GlaxoSmithKline
• Boehringer Ingelheim
• Teva Pharmaceutical
• Mylan
• Otsuka Pharmaceutical
• Johnson & Johnson
• Aurobindo Pharma
• Acorda Therapeutics
• Zydus Cadila

The Global Opioid Tolerance Treatment Market is segmented as follows:

Global Opioid Tolerance Treatment Market: Drug Analysis

• NMDA Antagonists
  • Ketamine
  • Dextromethorphan
  • Others
• Alpha2-Adrenoceptor Agonists
  • Clonidine
  • Tizanidine
  • Others
• Others

Global Opioid Tolerance Treatment Market: Opioid Tolerance Type Analysis

• Innate Tolerance
• Acquired Tolerance

Global Opioid Tolerance Treatment Market: Administration Route Analysis

• Enteral
• Parenteral

Global Opioid Tolerance Treatment Market: End-User Analysis

• Hospitals and ASCs
• Rehabilitation Centers
• Others (Homecare Settings and Research Institutes)

Global Opioid Tolerance Treatment Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa